Frequently Asked Question:
The global intraoperative neuromonitoring (IONM) market was valued at USD 3.5 Billion in 2022.
The intraoperative neuromonitoring (IONM) market is expected to grow at a CAGR of 5.10% between 2023 and 2030, reaching USD 4.9 Billion in 2030.
The insourced type led the market, accounting for more than 55.19% of global sales in 2022.
When compared to neurosurgery and orthopedic surgery, the ENT (Ear, Nose, and Throat) surgery section is a minor use of intraoperative neuromonitoring (IONM).
Hospitals are expected to expand at the quickest CAGR throughout the projection period.
North America dominated the market, accounting for more than 49.30% of worldwide revenue in 2022.
The top players include Computational Diagnostics Inc., Inomed Medizintechnik GmbH, Neuro Alert, Medtronic PLC and Natus Medical Incorporated. Other major players include Neuro Style, Nihon Kohden Corporation, Nuvasive Inc, Specialty Care Inc and Technomed.
Neurological disorders are growing more widespread, and the number of surgeries and technological developments is increasing as the major market drivers.
Inadequate Knowledge and Skilled Professionals, as well as the High Cost of Intraoperative Neuromonitoring (IONM) Services are the major market restraints.
Remote control devices are becoming more popular, and a growing number of surgical procedures are being conducted are the major opportunities in the intraoperative neuromonitoring (IONM) industry.